4-109919790-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000265171.10(EGF):​c.127+6328A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.497 in 151,170 control chromosomes in the GnomAD database, including 20,383 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 20383 hom., cov: 31)

Consequence

EGF
ENST00000265171.10 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.97

Publications

3 publications found
Variant links:
Genes affected
EGF (HGNC:3229): (epidermal growth factor) This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
EGF Gene-Disease associations (from GenCC):
  • familial primary hypomagnesemia with normocalciuria and normocalcemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal hypomagnesemia 4
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.676 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000265171.10. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGF
NM_001963.6
MANE Select
c.127+6328A>G
intron
N/ANP_001954.2
EGF
NM_001178130.3
c.127+6328A>G
intron
N/ANP_001171601.1
EGF
NM_001178131.3
c.127+6328A>G
intron
N/ANP_001171602.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGF
ENST00000265171.10
TSL:1 MANE Select
c.127+6328A>G
intron
N/AENSP00000265171.5
EGF
ENST00000503392.1
TSL:1
c.127+6328A>G
intron
N/AENSP00000421384.1
EGF
ENST00000509793.5
TSL:2
c.127+6328A>G
intron
N/AENSP00000424316.1

Frequencies

GnomAD3 genomes
AF:
0.497
AC:
75081
AN:
151052
Hom.:
20342
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.668
Gnomad AMI
AF:
0.487
Gnomad AMR
AF:
0.512
Gnomad ASJ
AF:
0.489
Gnomad EAS
AF:
0.694
Gnomad SAS
AF:
0.509
Gnomad FIN
AF:
0.352
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.399
Gnomad OTH
AF:
0.489
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.497
AC:
75177
AN:
151170
Hom.:
20383
Cov.:
31
AF XY:
0.496
AC XY:
36674
AN XY:
73882
show subpopulations
African (AFR)
AF:
0.668
AC:
27189
AN:
40684
American (AMR)
AF:
0.511
AC:
7798
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.489
AC:
1694
AN:
3466
East Asian (EAS)
AF:
0.695
AC:
3578
AN:
5148
South Asian (SAS)
AF:
0.510
AC:
2453
AN:
4808
European-Finnish (FIN)
AF:
0.352
AC:
3722
AN:
10564
Middle Eastern (MID)
AF:
0.510
AC:
150
AN:
294
European-Non Finnish (NFE)
AF:
0.399
AC:
27110
AN:
67936
Other (OTH)
AF:
0.494
AC:
1040
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1770
3539
5309
7078
8848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.464
Hom.:
2242
Bravo
AF:
0.522
Asia WGS
AF:
0.601
AC:
2091
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.69
DANN
Benign
0.32
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2881559; hg19: chr4-110840946; API